BUZZ-GlaxoSmithKline: talk of breakup puts stock back on the radar

** Improving fundamental and technical picture for GlaxoSmithKline (Other OTC: GLAXF - news) puts pharma giant back on the radar after a lacklustre 2014 and 2015

** Shareholders and GSK senior management have talked up a possible break-up in January, with analysts now exploring the possibility of the co spinning off a number of divisions

** High (LSE: 0O9Y.L - news) profile shareholder Neil Woodford said on Jan 8 GSK was "like 4 FTSE 100 companies bolted together", urging a break-up

** CEO Andrew Witty said at the JPM healthcare conference on Jan 12 he was open to the idea, but said it may not become a reality for a year or two

** Analysts at Liberum and Aviate see a spin-off of co's ViiV HIV unit as most likely scenario

** Liberum estimates such a deal would provide around 20 pct upside

** Technical picture also brighter: stock showing signs of breaking 2.5 yr downtrend against the Stoxx 600 Health Care index. Chart: http://reut.rs/1RpYcNj

** Co's generous 6 pct dividend yield cited by multiple traders as enough incentive to own stock until turnaround materialises

(RM (LSE: RM.L - news) : alasdair.pal.thomsonreuters.com@reuters.net)